BioLargo's Medical Subsidiary Files 510(k) with FDA for its Novel Wound Care Technology
Westminster, CA , Sept. 28, 2017 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), a sustainable science and technology company that delivers practical solutions for clean water, clean air, and advanced wound care, announced today its subsidiary Clyra …